Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does prasugrel achieve superior platelet inhibition when compared with clopidogrel in patients with CAD?

Nature Clinical Practice Cardiovascular Medicine volume 3, pages 648–649 (2006)Cite this article

boxed-textJernberg T et al. (2006) Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease. Eur Heart J 27: 1166–1173

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Müller I et al. (2003) Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement. Thromb Haemost 89: 783–787

    Article  Google Scholar 

  2. Matetzky S et al. (2004) Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation 109: 3171–3175

    Article  CAS  Google Scholar 

  3. Wiviott SD et al. (2005) Randomized comparison of prasugrel (CS-747, LY640315), a novel thienopyridine P2Y12 antagonist, with clopidogrel in percutaneous coronary intervention: results of the Joint Utilization of Medications to Block Platelets Optimally (JUMBO)-TIMI 26 trial. Circulation 111: 3366–3373

    Article  CAS  Google Scholar 

  4. Jakubowski JA et al. (2006) The platelet inhibitory effects and pharmacokinetics of prasugrel after administration of loading and maintenance doses in healthy subjects. J Cardiovasc Pharmacol 47: 377–384

    CAS  PubMed  Google Scholar 

  5. Müller I et al. (2001) Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement. Heart 85: 92–93

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Carol Lovegrove, Freelance Medical Writer.

Author information

Authors and Affiliations

  1. professor and Director of the Department of Medicine, Eberhard-Karls University of Tübingen, Germany

    Meinrad Gawaz

Authors
  1. Meinrad Gawaz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Meinrad Gawaz.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gawaz, M. Does prasugrel achieve superior platelet inhibition when compared with clopidogrel in patients with CAD?. Nat Rev Cardiol 3, 648–649 (2006). https://doi.org/10.1038/ncpcardio0690

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio0690

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing